Celltrion Presents New LIBERTY Study Analyses at ECCO Congress on SC Infliximab Efficacy and Safety Celltrion presented new post hoc analyses of its pivotal LIBERTY studies (LIBERTY-CD and LIBERTY-UC) at…
CareDx Study Shows AlloSeq cfDNA Accurately Detects Organ Rejection CareDx, Inc. (Nasdaq: CDNA), a leader in precision medicine for transplant patients, announced new findings published in Transplant International. The study…
Precision BioSciences Announces Early Safety and Antiviral Results for PBGENE-HBV in ELIMINATE-B Trial Precision BioSciences, Inc. (Nasdaq: DTIL), a clinical stage gene editing company utilizing its novel proprietary ARCUS® platform…
WELIREG® (belzutifan) Gains First European Commission Approval for Two Indications Merck (NYSE: MRK), known as MSD outside the United States and Canada, has announced that the European Commission (EC) has…
ICC Tribunal Rules in Favor of AOP Health in BESREMi® Arbitration Case An International Chamber of Commerce (ICC) tribunal has issued a partial final award in favor of AOP Orphan…
Abridge Secures $250M Series D, Unveils New Contextual Reasoning Engine for Healthcare Abridge, a leader in generative AI for clinical conversations, has secured a $250 million Series D funding round.…
Two Dedicated Team Members Awarded the Graeme Rabbits Scholarship Two deserving individuals are one step closer to achieving their career aspirations in behavioural neuroscience and social work, thanks to receiving…
Samsung Bioepis Gains EC Approval for Denosumab Biosimilar (OBODENCE™, XBRYK™) Samsung Bioepis Co., Ltd. has announced that the European Commission (EC) has granted marketing authorization for two denosumab biosimilars, OBODENCE™…
FDA Grants Full Approval to Deciphera’s ROMVIMZA™ (vimseltinib) for Symptomatic TGCT Ono Pharmaceutical Co., Ltd. has announced that the U.S. Food and Drug Administration (FDA) has granted full approval for…
IMFINZI® Regimen Boosts Survival in Muscle-Invasive Bladder Cancer: NIAGARA Phase III Post-Hoc Analysis A post-hoc exploratory analysis from the Phase III NIAGARA trial has shown that AstraZeneca’s IMFINZI® (durvalumab), when…
Sigma Healthcare Merges with Chemist Warehouse Sigma Healthcare has officially merged with Chemist Warehouse Group (CW), marking a monumental moment for both companies. As of today, the newly merged entity’s…
Pro Medicus Limited Q2 Results Leading health imaging company Pro Medicus Limited (ASX: PME) reported a strong financial performance for the first half of the 2024 fiscal year, posting a…